Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy.

导出 LinkOut

翻译打印收藏纠错

作者： Lin,Kang ^[1] ; Vanessa,Voskinarian-Berse ; Eric,Law ; Tiffany,Reddin ; Mohit,Bhatia ; Alexandra,Hariri ; Yuhong,Ning ; David,Dong ; Timothy,Maguire ; Martin,Yarmush ; Wolfgang,Hofgartner ; Stewart,Abbot ; Xiaokui,Zhang ; Robert,Hariri

作者单位： Celgene Cellular Therapeutics Warren, NJ, USA. ^[1]

关键词 anti-tumor cytolytic activity cellular immunotherapy ex vivo expansion miRNA placental-derived natural killer cells

DOI 10.3389/fimmu.2013.00101

PMID 23641243

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览114

Frontiers in immunology

2013年4卷

101页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy.

Frontiers in immunology

相似文献

Frontiers in immunology

相关期刊

检索历史清除